Rearrangements of chromosome 3q26, which lead to upregulation of EVI1, frequently occur in myeloid malignant diseases including MDS, AML, and chronic myeloid leukemia (CML) (8–10). This evidence concerns the gene RUNX1 and myelodysplastic syndrome.